JP2004535428A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535428A5 JP2004535428A5 JP2003506269A JP2003506269A JP2004535428A5 JP 2004535428 A5 JP2004535428 A5 JP 2004535428A5 JP 2003506269 A JP2003506269 A JP 2003506269A JP 2003506269 A JP2003506269 A JP 2003506269A JP 2004535428 A5 JP2004535428 A5 JP 2004535428A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- added
- reaction
- filtered
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *=C(c1ccccc1)OCC(OCC1)S1=O Chemical compound *=C(c1ccccc1)OCC(OCC1)S1=O 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- IJCKBIINTQEGLY-UHFFFAOYSA-N CC(NC(C=CN1)=NC1=O)=O Chemical compound CC(NC(C=CN1)=NC1=O)=O IJCKBIINTQEGLY-UHFFFAOYSA-N 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M Copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- YKFRUJSEPGHZFJ-UHFFFAOYSA-N N-trimethylsilylimidazole Chemical compound C[Si](C)(C)N1C=CN=C1 YKFRUJSEPGHZFJ-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- -1 pyrimidine compound Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L 7681-57-4 Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- OZSOMHDRIREFKV-UHFFFAOYSA-N O=C(c1ccccc1)OCNC(OCC1)S1=O Chemical compound O=C(c1ccccc1)OCNC(OCC1)S1=O OZSOMHDRIREFKV-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
Description
3)(+/−)−cis, trans−2−ベンゾイルオキシメチル−4−(N−アセチルシトシン−1'−イル)−1,3−オキサチオラン
化合物(3)をCH2Cl2(20mL/g)に溶解して、−15℃に冷却した。内部温度を−5℃以下に保ちながらアミン(1当量〜2当量の間)を加え、続いてTMSI(2当量〜5当量の間)を加え、そして化合物(3)が消失するまで−5℃〜−10℃で撹拌した。CuCl(20%)およびピリミジン化合物(1.1当量)を加えた。反応混合物を加温して、反応が完了したことをTLCが示すまで5℃〜10℃の間で保った。反応混合物を5%NH4OHに注ぎ、固体の沈殿が検出されなくなるまで10分間撹拌した。有機層を分離し、水層をCH2Cl2で抽出した。有機層を、水、2%HCl、希Na2S2O3で洗浄した。洗浄された有機層を蒸発させて、生成物の化合物(4)を得た。この工程に対する結果が表2に示される。
5)(−)または(+)の2−ベンゾイルオキシメチル−1,3−オキサチオラン−S−オキシドを使用する2−ベンゾイルオキシメチル−4−(N−アセチルシトシン−1'−イル)−1,3−オキサチオランの合成
エナンチオマー的に純粋な化合物(3a)をCH2Cl2(10mL/g)に溶解して、反応温度に冷却した。内部温度を−5℃以下に保ちながらアミンを加え、続いてTMSIを加え、そして化合物(3a)が消失するまで−5℃〜−40℃で撹拌した。CuCl(20%)およびピリミジン化合物(1.1当量)を加えた。反応混合物を加温し、そして反応が完了したことがTLCにより示されるまで−40℃〜30℃の間で保った。反応物を0℃〜5℃に冷却した。セライト(12g、100%w/w)を懸濁液に加え、撹拌した。濃水酸化アンモニウムをゆっくり加え、懸濁液の温度を0℃〜10℃の間で保った。0℃〜5℃で撹拌した。懸濁液をろ過し、ケークをジクロロメタンに再懸濁した。撹拌し、その後、ろ過した。相を分離し、水相をジクロロメタンで抽出した。有機層を一緒にして、2%の水酸化アンモニウム溶液、水、2%の塩酸溶液、2%のメタ重亜硫酸ナトリウム溶液、そして飽和重炭酸ナトリウム溶液で洗浄した。有機相を硫酸マグネシウムで乾燥し、ろ過し、その後、真空下で容積を減らして、粗製の塩基結合物質をベージュ色の固体として得た。固体をEtOAcに溶解して、結晶化させた。懸濁液を0℃〜5℃で撹拌し、その後、ろ過した。固体を真空下で乾燥して、純粋な塩基結合生成物を薄いベージュ色の固体として得た。この工程に対する結果が表4および表5に示される。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29807901P | 2001-06-15 | 2001-06-15 | |
PCT/CA2002/000899 WO2002102796A1 (en) | 2001-06-15 | 2002-06-14 | Stereoselective method for the preparation of nucleoside analogues |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2004535428A JP2004535428A (ja) | 2004-11-25 |
JP2004535428A5 true JP2004535428A5 (ja) | 2006-01-05 |
JP4542776B2 JP4542776B2 (ja) | 2010-09-15 |
Family
ID=23148927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003506269A Expired - Fee Related JP4542776B2 (ja) | 2001-06-15 | 2002-06-14 | ヌクレオシドアナログを調製するための立体選択的な方法 |
Country Status (29)
Country | Link |
---|---|
US (2) | US7109334B2 (ja) |
EP (2) | EP1632490B1 (ja) |
JP (1) | JP4542776B2 (ja) |
KR (1) | KR100832617B1 (ja) |
CN (1) | CN1297553C (ja) |
AP (1) | AP1559A (ja) |
AT (2) | ATE313542T1 (ja) |
AU (2) | AU2002344862C1 (ja) |
BR (2) | BRPI0210444B1 (ja) |
CA (1) | CA2449338C (ja) |
CO (1) | CO5550497A2 (ja) |
CY (1) | CY1107805T1 (ja) |
DE (2) | DE60208202T2 (ja) |
DK (2) | DK1632490T3 (ja) |
EA (1) | EA006372B1 (ja) |
ES (2) | ES2254695T3 (ja) |
HK (1) | HK1070652A1 (ja) |
HR (1) | HRP20031021B1 (ja) |
IL (2) | IL159139A0 (ja) |
MX (1) | MXPA03011627A (ja) |
NO (1) | NO326135B1 (ja) |
NZ (1) | NZ529906A (ja) |
OA (1) | OA12628A (ja) |
PL (2) | PL215267B1 (ja) |
PT (1) | PT1632490E (ja) |
RS (1) | RS50868B (ja) |
SI (2) | SI1406896T1 (ja) |
WO (1) | WO2002102796A1 (ja) |
ZA (1) | ZA200309307B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7501514B1 (en) | 2003-10-15 | 2009-03-10 | Shire Biochem, Inc. | Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides |
JP4653966B2 (ja) * | 2004-04-19 | 2011-03-16 | ダイセル化学工業株式会社 | 2−ベンゾイルオキシアセトアルデヒド誘導体の製造法 |
IN2015DN02599A (ja) * | 2007-09-28 | 2015-09-18 | Avexa Ltd | |
US20130165350A1 (en) * | 2011-12-22 | 2013-06-27 | Affymetrix, Inc. | Surface linkers for array synthesis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR840001591A (ko) * | 1981-09-29 | 1984-05-07 | 구라바야시 이꾸시로 | 당케탈류의 제조방법 |
AU8864191A (en) * | 1990-11-13 | 1992-06-11 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US5532349A (en) * | 1993-07-20 | 1996-07-02 | Mitsui Toatsu Chemicals, Inc. | Process for producing 1-(2'-deoxy-β-D-erythro-pentofuranosyl)-5-trifluoromethyluracil derivatives |
CA2714085C (en) * | 1998-08-12 | 2013-02-05 | Emory University | Method of manufacture of 1,3-oxathiolane nucleosides |
-
2002
- 2002-06-14 AP APAP/P/2003/002948A patent/AP1559A/en active
- 2002-06-14 AU AU2002344862A patent/AU2002344862C1/en not_active Ceased
- 2002-06-14 EP EP05017130A patent/EP1632490B1/en not_active Expired - Lifetime
- 2002-06-14 EA EA200400042A patent/EA006372B1/ru not_active IP Right Cessation
- 2002-06-14 BR BRPI0210444-0A patent/BRPI0210444B1/pt unknown
- 2002-06-14 IL IL15913902A patent/IL159139A0/xx unknown
- 2002-06-14 SI SI200230273T patent/SI1406896T1/sl unknown
- 2002-06-14 DE DE60208202T patent/DE60208202T2/de not_active Expired - Lifetime
- 2002-06-14 NZ NZ529906A patent/NZ529906A/xx not_active IP Right Cessation
- 2002-06-14 CA CA2449338A patent/CA2449338C/en not_active Expired - Fee Related
- 2002-06-14 JP JP2003506269A patent/JP4542776B2/ja not_active Expired - Fee Related
- 2002-06-14 US US10/170,418 patent/US7109334B2/en not_active Expired - Fee Related
- 2002-06-14 ES ES02742572T patent/ES2254695T3/es not_active Expired - Lifetime
- 2002-06-14 CN CNB028159624A patent/CN1297553C/zh not_active Expired - Fee Related
- 2002-06-14 PL PL366907A patent/PL215267B1/pl unknown
- 2002-06-14 SI SI200230631T patent/SI1632490T1/sl unknown
- 2002-06-14 WO PCT/CA2002/000899 patent/WO2002102796A1/en active IP Right Grant
- 2002-06-14 MX MXPA03011627A patent/MXPA03011627A/es active IP Right Grant
- 2002-06-14 KR KR1020037016301A patent/KR100832617B1/ko not_active IP Right Cessation
- 2002-06-14 AT AT02742572T patent/ATE313542T1/de active
- 2002-06-14 DK DK05017130T patent/DK1632490T3/da active
- 2002-06-14 RS YUP-975/03A patent/RS50868B/sr unknown
- 2002-06-14 PT PT05017130T patent/PT1632490E/pt unknown
- 2002-06-14 ES ES05017130T patent/ES2293445T3/es not_active Expired - Lifetime
- 2002-06-14 EP EP02742572A patent/EP1406896B8/en not_active Expired - Lifetime
- 2002-06-14 AT AT05017130T patent/ATE370945T1/de active
- 2002-06-14 DK DK02742572T patent/DK1406896T3/da active
- 2002-06-14 OA OA1200300329A patent/OA12628A/en unknown
- 2002-06-14 DE DE60222031T patent/DE60222031T2/de not_active Expired - Lifetime
- 2002-06-14 BR BR0210444-0A patent/BR0210444A/pt not_active IP Right Cessation
- 2002-06-14 PL PL401835A patent/PL218777B1/pl unknown
-
2003
- 2003-11-28 ZA ZA2003/09307A patent/ZA200309307B/en unknown
- 2003-12-01 IL IL159139A patent/IL159139A/en not_active IP Right Cessation
- 2003-12-09 HR HR20031021A patent/HRP20031021B1/xx not_active IP Right Cessation
- 2003-12-12 NO NO20035556A patent/NO326135B1/no not_active IP Right Cessation
-
2004
- 2004-01-14 CO CO04002061A patent/CO5550497A2/es active IP Right Grant
-
2005
- 2005-04-18 HK HK05103299A patent/HK1070652A1/xx not_active IP Right Cessation
-
2006
- 2006-04-07 US US11/399,502 patent/US7230100B2/en not_active Expired - Fee Related
-
2007
- 2007-11-15 CY CY20071101481T patent/CY1107805T1/el unknown
-
2008
- 2008-08-01 AU AU2008203443A patent/AU2008203443B2/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012510524A5 (ja) | ||
JP2008510762A5 (ja) | ||
JP2012528105A5 (ja) | ||
JP2010513494A5 (ja) | ||
JP2022031717A5 (ja) | ||
RU2007132260A (ru) | Синтез арилпирролидонов | |
JP2008516005A (ja) | レトロゾールの改良された調製方法 | |
DE60326341D1 (de) | Verfahren zur herstellung von anthranilsäurederivat-hydrat | |
CA2773012A1 (en) | Process for the preparation of lenalidomide | |
US20040266800A1 (en) | Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof | |
JP2000063334A (ja) | エンイン誘導体の新規製造中間体及びその製造法 | |
JP2004535428A5 (ja) | ||
JP2010510253A5 (ja) | ||
TWI325416B (en) | Improved process for the production of nitroisourea derivative | |
WO2012037764A1 (zh) | (e)-2-[2-(6-氯嘧啶-4-基氧)苯基]-3-甲氧基丙烯酸甲酯的制备方法 | |
JP2012503653A5 (ja) | ||
CN101311179A (zh) | 制备噻吩并-苯并二氮杂卓类化合物的改进方法 | |
JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
WO2020110146A1 (en) | Process for the preparation of high pure eribulin and its mesylate salt | |
JP2020536898A5 (ja) | ||
JP2001261653A5 (ja) | ||
JP2007506794A (ja) | ナルウェジンアミド誘導体の分割 | |
JP7323876B2 (ja) | クロピドグレル硫酸塩のi型結晶の製造方法 | |
JP2001261647A5 (ja) | ||
RU2818458C2 (ru) | Способы и промежуточные соединения для получения ингибитора btk |